Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FF-10501-01 + Azacitidine in Myelodysplastic Syndrome
NCT03486353Phase 2Withdrawn
- Sponsor
- Fujifilm Pharmaceuticals
- Start
- Oct 2019
- Primary completion
- Oct 2019
01
Overview
A Phase 2 trial of FF-10501-01 in myelodysplastic syndrome (MDS), sponsored by Fujifilm Pharmaceuticals. Planned start Oct 2019; status: withdrawn.
02
Drugs
FF-10501-01
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT03486353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03486353.